ARCHIVES

Severe Shortages Of Many Cancer Drugs Affecting Practices

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Steiner To Leave ICC, Says Someone Else May Do Better

December 10, 1982